论文信息 - CRISPR/Cas Powered Multiplexed Biosensing.

CRISPR/Cas Powered Multiplexed Biosensing.

Multiplexed CRISPR/Cas biosensing offers various possibilities for diagnosing different diseases by analyzing many analytes from one single specimen. However, in this relatively new field, nearly no multiplexing approaches exist, as many challenges need to be addressed. We discuss the reasons behind it and possible strategies to push the multiplexing level.

[1] D. Beebe,et al. The present and future role of microfluidics in biomedical research , 2014, Nature.

[2] Richard Bruch,et al. Multiplexed Point-of-Care Testing – xPOCT , 2017, Trends in biotechnology.

[3] Hayden C. Metsky,et al. Field-deployable viral diagnostics using CRISPR-Cas13 , 2018, Science.

[4] Mandeep Sandhu,et al. Detection of unamplified target genes via CRISPR–Cas9 immobilized on a graphene field-effect transistor , 2019, Nature Biomedical Engineering.

[5] Da Xing,et al. Clustered Regularly Interspaced Short Palindromic Repeats/Cas9 Triggered Isothermal Amplification for Site-Specific Nucleic Acid Detection. , 2018, Analytical chemistry.

[6] James J. Collins,et al. Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6 , 2018, Science.

[7] James F Rusling,et al. Automated multiplexed ECL Immunoarrays for cancer biomarker proteins. , 2015, Analytical chemistry.

[8] Guozhen Liu,et al. CRISPR/Cas Systems towards Next-Generation Biosensing. , 2019, Trends in biotechnology.

[9] Gerald Urban,et al. Multianalyte Antibiotic Detection on an Electrochemical Microfluidic Platform. , 2016, Analytical chemistry.